Article Information
- Received January 22, 2009
- Revision received June 12, 2009
- Accepted June 17, 2009
- First published August 5, 2009.
- Version of record published August 5, 2009.
Author Information
- Michael E. Hildebrand 1 ,*,
- Philippe Isope 2 ,*,
- Taisuke Miyazaki 6 ,
- Toshitaka Nakaya 6 ,
- Esperanza Garcia 1 ,
- Anne Feltz 2 ,
- Toni Schneider 5 ,
- Jürgen Hescheler 5 ,
- Masanobu Kano 3 ,
- Kenji Sakimura 4 ,
- Masahiko Watanabe 6 ,
- Stéphane Dieudonné 2 , and
- Terrance P. Snutch 1
- 1Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada,
- 2Laboratoire de Neurobiologie, Ecole Normale Supérieure, Centre National de la Recherche Scientifique, 75005 Paris, France,
- 3Department of Neurophysiology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan,
- 4Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan,
- 5Institute of Neurophysiology and Center for Molecular Medicine Cologne, University of Cologne, D-50931 Cologne, Germany, and
- 6Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan
- Correspondence should be addressed to Dr. Terrance P. Snutch, Michael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada. snutch{at}msl.ubc.ca
Author contributions
-
↵*M.E.H. and P.I. contributed equally to this work.
Disclosures
- Received January 22, 2009.
- Revision received June 12, 2009.
- Accepted June 17, 2009.
-
This work is supported by an operating grant from the Canadian Institutes of Health Research and a Tier 1 Canada Research Chair in Biotechnology and Genomics-Neurobiology (T.P.S.), by the Centre National pour la Recherche Scientifique, L'Ecole Normale Supérieure, and the L'Agence Nationale pour La Recherche and Human Frontier Science Program, and by Grants-in-Aid for Scientific Research (17023021 and 17100004) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. M.E.H. was supported by trainee fellowships from the Natural Sciences and Engineering Research Council of Canada and Michael Smith Foundation for Health Research. We thank Drs. Brian MacVicar, Boris Barbour, and Clement Léna for suggestions and comments. We thank Neuromed Pharmaceuticals for kindly providing HEK 293 cell lines stably expressing rat brain Cav3.1, Cav3.2, or Cav3.3 subunits.
- Correspondence should be addressed to Dr. Terrance P. Snutch, Michael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada. snutch{at}msl.ubc.ca
Online Impact